BioPorto denies rumors in the market
![Foto: PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article6215986.ece/ALTERNATES/schema-16_9/BioPorto.jpg)
BioPorto says rumors have circulated in the market that the company's divisional NGAL cut-off patent application no. EP2128625 has been rejected by the European Patent Office (EPO) – something which the company has now denied in a stock market release.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
BioPorto loses crucial patent trial
For abonnenter
”It’s not like I’m leaving in tears today”
For abonnenter
BioPorto CFO switches to Novo-owned company
For abonnenter